Immunosuppressive therapies for alopecia areata during COVID-19: A cross-sectional survey study

Flanagan KE, Pathoulas JT, Walker CJ, et al. Immunosuppressive therapies for alopecia areata during COVID-19: A cross-sectional survey study. Dermatol Ther. 2021;34(2):e14762.

PubMed

Last updated on 10/05/2026
PubMed

Recent Publications

Response to Teachout et al "Response to Ezzat et al, "Response to Rypka et al, 'A single center retrospective cohort study of hydroxychloroquine-related adverse events in adults with lymphocytic cicatricial alopecia'"
Enhancing gender-affirming hair loss assessment: Comment on "Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy"
Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia
Liver toxicity, a rare side effect of using turmeric supplements for hair loss
Response to Huang et al.'s ''Real-world efficacy of ritlecitinib in treating alopecia areata across various anatomical sites: potential rapid response predictors"
Switching between Janus kinase inhibitors for treatment of alopecia areata: A multicenter retrospective review

Senna Hair Lab
Lahey Hair Loss Center of Excellence
67 South Bedford Street, Suite 100E
Burlington, MA 01803
Appointments: 781.744.8444 · Directions

Conditions · Clinical trials · Publications · Media · Join the lab · Team

The Senna Hair Lab is the research arm of the Lahey Hair Loss Center of Excellence, home of the H.A.I.R. unit led by Dr. Senna.

Instagram
LinkedIn

Advancing the
science and care
of hair loss.

Secondary menu

About
Team
Research
News

Powered byOpenScholar^®Admin Login